Can You Stop Using Wegovy, and What Actually Happens If You Do?

Step 1: What the medicine is actually doing while you take it

Semaglutide, the active ingredient in Wegovy, works by activating GLP-1 receptors in the brain and gut. It slows the movement of food through the stomach and signals satiety to the hypothalamus, the part of the brain that governs hunger and energy balance. The effect is continuous: as long as a dose is active in your system, appetite is blunted and portion sizes feel manageable. This is why, for many people, eating less does not feel like deprivation on treatment in the way it did before.

The key thing to understand is that semaglutide does not reset the body's weight set-point. Obesity is a chronic condition with a biological basis, and the medicine manages it in the same way that medication manages blood pressure, effectively, but only whilst it is being taken. The NHS semaglutide patient information page is clear that Wegovy is intended alongside reduced-calorie eating and increased activity, not as a standalone fix. Stopping the injection does not mean the work you have put into lifestyle changes disappears; it does mean the pharmacological appetite suppression stops.

Semaglutide's half-life is roughly one week, so a missed dose is noticeable within days, and most of the drug has cleared within two to three weeks of a final injection. Appetite can return quite quickly for some people, more gradually for others.

Step 2: The evidence on what happens to weight after stopping

The STEP 1 extension study (following participants from the original 68-week trial after they stopped semaglutide) found that within 12 months of discontinuation, participants had regained about two-thirds of the weight they had lost. Cardiovascular risk markers also returned toward baseline levels. This is published evidence, not speculation, and it is the honest picture any prescriber will give you.

It does not mean stopping is the wrong choice for you. It means the decision needs to be made with eyes open. Some people stop because they reach a stable, healthier weight and want to try maintaining it without medication. Others stop because of side effects they cannot tolerate. Some stop for financial reasons, it is worth looking at a realistic Wegovy cost comparison before concluding the expense is unavoidable, since providers and price structures vary. Some stop because life intervenes: surgery, pregnancy planning, an illness. Each of those reasons carries a different set of clinical considerations.

The STEP 1 trial enrolled over 1,900 adults (a substantial evidence base) and the weight-regain pattern was consistent across the group. What it cannot tell you is what will happen to your weight, because individual responses vary considerably.

Step 3: How to stop safely if that is the right decision

There is no clinical requirement to taper semaglutide before stopping; the drug's own pharmacokinetics mean it clears progressively as doses are missed. Some prescribers may advise a structured approach (stepping down through lower doses rather than stopping abruptly) if there are tolerability or clinical reasons to do so. That is a conversation to have, not a rule to follow unilaterally.

Practical steps worth covering with your prescriber before stopping include: whether any underlying conditions that qualified you for treatment need review; what ongoing support looks like (dietary guidance, activity planning, follow-up); and how long after stopping it is safe to try to conceive, if that is relevant. The MHRA advises that women who might become pregnant should discuss contraception and timing with their clinician before stopping or continuing GLP-1 treatment.

If you are thinking about stopping because Wegovy is not working as well as it once did, that is a separate conversation, one about whether a dose review or a different medicine might be more appropriate than stopping altogether. Our guide on what happens if weight loss slows on Wegovy covers that question directly. And if you are weighing up whether to pause rather than stop permanently, the considerations around temporarily pausing Wegovy are slightly different again.

Step 4: What happens after, and what the evidence says about restarting

Many people who stop Wegovy do restart it, sometimes after a break of weeks or months, sometimes after trying to maintain weight through lifestyle changes alone. There is no clinical evidence that stopping and restarting is harmful, provided there is prescriber oversight and the same eligibility criteria still apply. The medicine is not licensed for continuous lifelong use without review, but NICE's appraisal of semaglutide under TA875 recommends it for up to two years within specialist services; private prescribers follow the licensed indication and clinical judgement.

The afternoon after stopping, or the morning you realise your appetite has come back properly for the first time in months, can feel disorienting. A question our prescribers hear regularly is whether that hunger surge is unusual or a sign something went wrong. It is neither, it is the medicine clearing. What matters is what you do with that moment: whether there is a plan in place, support available, and someone clinical to speak to if things feel unmanageable.

If you are still deciding whether Wegovy is right for you in the first place, or exploring how it compares with other licensed treatments, including those available through the Wegovy API programme, the weight-loss treatment overview is a good starting point. For people already on treatment who want to understand the broader picture of what using Wegovy involves month to month, that page goes into more detail. The general background on semaglutide as a medicine covers the mechanism and evidence in full.